NCT00246064View on ClinicalTrials.gov

The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

November 30, 2003

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

infliximab

All Listed Sponsors
lead

Centocor Ortho Biotech Services, L.L.C.

INDUSTRY

NCT00246064 - The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol | Biotech Hunter | Biotech Hunter